Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer (Q43744356)

26 November 2017

title

Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer (English)

1 reference

26 November 2017

1 reference

Javid G

1

1 reference

26 November 2017

Masoodi I

2

1 reference

26 November 2017

Zargar SA

3

1 reference

26 November 2017

Khan BA

4

1 reference

26 November 2017

Yatoo GN

5

1 reference

26 November 2017

Shah AH

6

1 reference

26 November 2017

Gulzar GM

7

1 reference

26 November 2017

Sodhi JS

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Medicine

26 November 2017

published in

1 reference

26 November 2017

volume

111

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

280-284

1 reference

Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Heater probe thermocoagulation and multipolar electrocoagulation for arrest of peptic ulcer bleeding. A prospective, randomized comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers. A prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Action of human gastric juice on human blood clots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Antisecretory therapy for bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

A comparison of omeprazole and placebo for bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Endoscopy in gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

The Visible Vessel as an Indicator of Uncontrolled or Recurrent Gastrointestinal Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Bleeding duodenal ulcer. A prospective evaluation of risk factors for rebleeding and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Injection of nonvariceal bleeding lesions of the upper gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

The role of sustained achlorhydria in bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Omeprazole for bleeding PUD: do we finally have evidence for effective medical therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Therapy for bleeding peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

Endoscopic hemostasis by local injection of epinephrine and polidocanol in bleeding ulcer. A prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900812-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(01)00812-9

1 reference

26 November 2017

1 reference